Abstract
Using monoclonal antibodies, peripheral blood helper/inducer (OKT4) and cytotoxic/suppressor (OKT8) lymphocytes were measured in 14 normal controls, 36 patients with multiple sclerosis at different stages of the disease and 15 patients with isolated optic neuritis. Thirty-four of these individuals were studied on two or more occasions at intervals up to 340 days. Patients with multiple sclerosis in relapse had low levels of OKT8 cells (14.07% +/- 3.79) compared with controls (29.42% +/- 4.69) and this abnormality returned to normal within approximately one month of the onset of new symptoms. Further changes occurred with new relapses. Low OKT8 cells were also found in patients with isolated optic neuritis (18.76 +/- 3.71) or progressive multiple sclerosis (19.91% +/- 7.96); the same pattern of recovery was seen in these two groups as in patients with multiple sclerosis in relapse. In 25% patients studied on two or more occasions after an episode of demyelination abnormalities of lymphocyte subpopulations occurred which were not accompanied by new clinical symptoms or signs. Fluctuations of this kind did not occur in controls. The findings have implications for the pathogenesis and management of patients with multiple sclerosis.
Full text
PDF









Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen J. C., Sheremata W., Cosgrove J. B., Osterland K., Shea M. Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis. Neurology. 1976 Jun;26(6 Pt 1):579–583. doi: 10.1212/wnl.26.6.579. [DOI] [PubMed] [Google Scholar]
- Antel J. P., Arnason B. G., Medof M. E. Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol. 1979 Apr;5(4):338–342. doi: 10.1002/ana.410050406. [DOI] [PubMed] [Google Scholar]
- Antel J. P., Weinrich M., Arnason B. G. Mitogen responsiveness and suppressor cell function in multiple sclerosis. Influence of age and disease activity. Neurology. 1978 Oct;28(10):999–1003. doi: 10.1212/wnl.28.10.999. [DOI] [PubMed] [Google Scholar]
- Bach M. A., Phan-Dinh-Tuy F., Tournier E., Chatenoud L., Bach J. F., Martin C., Degos J. D. Deficit of suppressor T cells in active multiple sclerosis. Lancet. 1980 Dec 6;2(8206):1221–1223. doi: 10.1016/s0140-6736(80)92480-0. [DOI] [PubMed] [Google Scholar]
- Compston D. A., Batchelor J. R., Earl C. J., McDonald W. I. Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain. 1978 Sep;101(3):495–511. doi: 10.1093/brain/101.3.495. [DOI] [PubMed] [Google Scholar]
- Cook S. D., Dowling P. C. Multiple sclerosis and viruses: an overview. Neurology. 1980 Jul;30(7 Pt 2):80–91. doi: 10.1212/wnl.30.7_part_2.80. [DOI] [PubMed] [Google Scholar]
- Coyle P. K., Brooks B. R., Hirsch R. L., Cohen S. R., O'Donnell P., Johnson R. T., Wolinsky J. S. Cerebrospinal-fluid lymphocyte populations and immune complexes in active multiple sclerosis. Lancet. 1980 Aug 2;2(8188):229–232. doi: 10.1016/s0140-6736(80)90121-x. [DOI] [PubMed] [Google Scholar]
- Huddlestone J. R., Oldstone M. B. T suppressor (TG) lymphocytes fluctuate in parallel with changes in the clinical course of patients with multiple sclerosis. J Immunol. 1979 Oct;123(4):1615–1618. [PubMed] [Google Scholar]
- Hughes R. A., Gray I. A., Gregson N. A., Metcalfe R. A. Multiple sclerosis-lymphocyte transformation with multiple sclerosis and normal brain myelin basic protein and subcellular fractions. Acta Neurol Scand. 1982 Mar;65(3):161–173. doi: 10.1111/j.1600-0404.1982.tb03074.x. [DOI] [PubMed] [Google Scholar]
- Kam-Hansen S. Reduced number of active T cells in cerebrospinal fluid in multiple sclerosis. Neurology. 1979 Jun;29(6):897–899. doi: 10.1212/wnl.29.6.897. [DOI] [PubMed] [Google Scholar]
- Lisak R. P., Levinson A. I., Zweiman B., Abdou N. I. T and B lymphocytes in multiple sclerosis. Clin Exp Immunol. 1975 Oct;22(1):30–34. [PMC free article] [PubMed] [Google Scholar]
- Oger J., Szuchet S., Antel J., Arnason B. G. A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes. Nature. 1982 Jan 7;295(5844):66–68. doi: 10.1038/295066a0. [DOI] [PubMed] [Google Scholar]
- Prineas J. W., Connell F. The fine structure of chronically active multiple sclerosis plaques. Neurology. 1978 Sep;28(9 Pt 2):68–75. doi: 10.1212/wnl.28.9_part_2.68. [DOI] [PubMed] [Google Scholar]
- Prineas J. W., Wright R. G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest. 1978 Apr;38(4):409–421. [PubMed] [Google Scholar]
- Reinherz E. L., Moretta L., Roper M., Breard J. M., Mingari M. C., Cooper M. D., Schlossman S. F. Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med. 1980 Apr 1;151(4):969–974. doi: 10.1084/jem.151.4.969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reinherz E. L., Schlossman S. F. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14;303(7):370–373. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
- Routhier G., Epstein O., Janossy G., Thomas H. C., Sherlock, Kung P. C., Goldstein G. Effects of cyclosporin A on suppressor and inducer T lymphocytes in primary biliary cirrhosis. Lancet. 1980 Dec 6;2(8206):1223–1226. doi: 10.1016/s0140-6736(80)92481-2. [DOI] [PubMed] [Google Scholar]
- T-lymphocytes. Lancet. 1982 Apr 3;1(8275):778–779. [PubMed] [Google Scholar]
- Traugott U., Scheinberg L. C., Raine C. S. Multiple sclerosis: heterology among early T cells and Tg cells. Ann Neurol. 1982 Feb;11(2):182–186. doi: 10.1002/ana.410110212. [DOI] [PubMed] [Google Scholar]
- Turner A., Cuzner M. L., Davison A. N., Rudge P. On the role of sensitised T-lymphocytes in the pathogenesis of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1980 Apr;43(4):305–309. doi: 10.1136/jnnp.43.4.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
